BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld
Home
» Venture capital and other private biopharma financings in February 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Venture capital and other private biopharma financings in February 2020
March 6, 2020
No Comments
Venture capital and other private financings of private biopharma companies, including: Aivita, Alladapt, Alx Oncology, Aurora Science, Azafaros, Canbridge, Ikarovec, Inotrem, Kahr Medical, Kaipharm, Maat Pharma, Neotx, Novelty Nobility, Omass, Oncodna, Pentixapharm, Pinpoint, Sonoma, Spruce Biosciences, Valo, Volastra.
BioWorld
Analysis and data insight